<DOC>
	<DOCNO>NCT01189695</DOCNO>
	<brief_summary>The objective study determine efficacy ritonavir-boosted lopinavir monotherapy maintenance regimen HIV-1-infected patient previously fail Non-nucleoside reverse transcriptase inhibitor ( NNRTI ) base regimens currently receive salvage protease-inhibitor ( PI ) base regimen .</brief_summary>
	<brief_title>Maintenance Boosted Lopinavir Monotherapy Following Salvage Protease-inhibitor ( PI ) Based Regimen HIV With Non-nucleoside Reverse Transcriptase Inhibitors ( NNRTI ) Based Regimen Failure</brief_title>
	<detailed_description />
	<mesh_term>Ritonavir</mesh_term>
	<mesh_term>Lopinavir</mesh_term>
	<mesh_term>Protease Inhibitors</mesh_term>
	<mesh_term>Reverse Transcriptase Inhibitors</mesh_term>
	<criteria>age 1860 year document HIV infection previously fail NNRTIbased regimen history fail PIbased regimen receive ritonavirboosted PI + OBRs ( NRITs , etravirine , raltegravir ) HIV1 RNA &lt; 50 copies/ml least prior 6 month Pregnant breastfeed woman HBV coinfection treat TDF , FTC 3TC receive medication know potential significant drug interaction LPV/r life expectancy le 6 month serious systemic disease liver cirrhosis ChildPugh B/C , ESRD , malignancy hemoglobin &lt; 8 g/dl , platelet &lt; 50,000/mm3 , AST ALT &gt; 3 ULN , estimate creatinine clearance &lt; 50 mL/min</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>HIV AIDS</keyword>
	<keyword>Lopinavir</keyword>
	<keyword>Ritonavir</keyword>
	<keyword>Anti-Retroviral Agents</keyword>
	<keyword>treatment failure</keyword>
	<keyword>treatment experience</keyword>
	<keyword>NNRTI failure</keyword>
	<keyword>monotherapy</keyword>
</DOC>